FMW
GSK icon

Farr Miller & Washington’s GSK GSK Stock Holding History

Farr Miller & Washington’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$214K Sell
4,478
-160
-3% -$8.04K 0.01% 177
2021
Q2 		$231K Hold
4,638
– – 0.02% 173
2021
Q1 		$207K Hold
4,638
– – 0.01% 183
2020
Q4 		$213K Hold
4,638
– – 0.02% 170
2020
Q3 		$218K Buy
+4,638
New +$232K 0.02% 156

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Farr Miller & Washington's GSK Position: Q3 2021 in Review

Farr Miller & Washington reduced its GSK (GSK) stake by 3.4% in Q3 2021, selling an estimated $8.04K and leaving 4,478 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #177.

Farr Miller & Washington first reported a position in GSK in Q3 2020 and has held it in 5 quarters since. The position peaked at $231K in Q2 2021. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • Farr Miller & Washington held 4,478 shares of GSK worth $214K as of Q3 2021.
  • Farr Miller & Washington sold 160 GSK shares in Q3 2021, an estimated $8.04K.
  • GSK made up 0.01% of Farr Miller & Washington's portfolio in Q3 2021, its #177 holding.
  • Farr Miller & Washington first reported a position in GSK in Q3 2020 and has held it in 5 quarters since.
  • Farr Miller & Washington's GSK position peaked at $231K in Q2 2021.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.